previous compound ID: 449 next compound
InChIKey: DGFYECXYGUIODH-UHFFFAOYSA-N
SMILES: C1=CC(=C(C(=C1)Cl)CC(=O)N=C(N)N)Cl.Cl

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"GW Carlile" "DY Thomas" "JW Hanrahan" "J Liao" "SD Macknight" "R Robert" "B Kus" "D Rotin" "J Goepp" "E Matthes"

chemical graph of compound 449





CID is 71401
synonyms found at PubChem are:
guanfacine hydrochloride, GUANFACINE HCL, 29110-48-3, Tenex, Estulic, Intuniv, N-Carbamimidoyl-2-(2,6-dichlorophenyl)acetamide hydrochloride, Guanfacine (hydrochloride), Guanfacin hydrochloride, 29520-14-7, BS 100-141, Connexyn, N-Amidino-2-(2,6-dichlorophenyl)acetamide hydrochloride, LON 798, UNII-PML56A160O, N-(Aminoiminomethyl)-2,6-dichlorobenzeneacetamide hydrochloride, Tenex (TN), N-Amidino-2-(2,6-dichlorophenyl)acetamide monohydrochloride, EINECS 249-443-3, Guanfacine hydrochloride [USAN:JAN], SPD 503, MLS000069745, PML56A160O, BS-100-141, N-(Aminoiminomethyl)-2,6-dichlorophenylacetamide monohydrochloride, SPD-503, N-(diaminomethylidene)-2-(2,6-dichlorophenyl)acetamide hydrochloride, Benzeneacetamide, N-(aminoiminomethyl)-2,6-dichloro-, monohydrochloride, Guanfacine hydrochloride (JAN/USP), n-carbamimidoyl-2-(2,6-dichlorphenyl)acetamidhydrochlorid, SMR000058453, G 1043, DSSTox_CID_25157, DSSTox_RID_80708, DSSTox_GSID_45157, N (Aminoiminomethyl)-2,6-dichlorobenzeneacetamide, [(2,6-Dichlorophenyl)acetyl]guanidine Hydrochloride, N-(aminoiminomethyl)-2,6-dichloro-benzeneacetamide hydrochloride, CAS-29520-14-7, SR-01000075893, NCGC00015469-05, Guanfacin, SPD503, Prestwick_740, Intuniv (TN), GuanfacineHydrochloride, Guarfacine Hydrochloride, Guanfacine hydrochloride [USAN:USP:JAN], Guanfascine Hydrochloride, C9H9Cl2N3O.HCl, Opera_ID_1928, D0WD8M, AC1L2G3E, C9H10Cl3N3O, SCHEMBL41681, MLS001077329, MLS002222252, AC1Q3P39, CHEBI:5559, CHEMBL1200494, DTXSID2045157, SCHEMBL15603414, CTK8C3871, CTK8G0106, MolPort-003-666-686, MolPort-019-997-499, HMS1569C19, Pharmakon1600-01505435, 29110-47-2 (Parent), BCP21710, KS-000017QB, Tox21_110159, Tox21_500519, ANW-70740, BG0397, MFCD00798230, NSC759121, s4693, AKOS015966858, AKOS030242245, Tox21_110159_1, API0006740, CCG-213439, CCG-220339, CS-1254, LP00519, NSC-759121, NCGC00015469-09, NCGC00093914-01, NCGC00093914-02, NCGC00180965-01, NCGC00261204-01, AS-12253, BC202678, HY-17416, LS-28474, Guanfacine hydrochloride, >=98% (HPLC), AB0011596, AX8239284, KB-258655, TC-159485, EU-0100519, FT-0630546, FT-0698181, G0414, D00606, W-5123, A826918, J-017395, S-877503, SR-01000075893-1, SR-01000075893-3, SR-01000075893-6, Benzeneacetamide, N-(aminoiminomethyl)-2,6-dichloro-, hydrochloride (1:1), Guanfacine hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material, Guanfacine hydrochloride, United States Pharmacopeia (USP) Reference Standard, N-[bis(azanyl)methylidene]-2-[2,6-bis(chloranyl)phenyl]ethanamide hydrochloride, AKOS026750369